About: Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
AQSZF NYSE Aequus Pharmaceuticals Inc
Aequus Pharmaceuticals Inc share price
AQSZF price activity
Last Price
Change (24hr)
USD
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
AQSZF price performance
AQSZF details
AQSZF Market Signals